Literature DB >> 33923774

Myocardial Accumulations of Reg3A, Reg3γ and Oncostatin M Are Associated with the Formation of Granulomata in Patients with Cardiac Sarcoidosis.

Praveen Gajawada1, Ayse Cetinkaya1,2, Susanne von Gerlach3, Natalia Kubin1, Heiko Burger1,2, Michael Näbauer4, Carola Grinninger4, Andreas Rolf2,5, Markus Schönburg1,2, Yeong-Hoon Choi1,2,6, Thomas Kubin1, Manfred Richter1,2.   

Abstract

Cardiac sarcoidosis (CS) is a poorly understood disease and is characterized by the focal accumulation of immune cells, thus leading to the formation of granulomata (GL). To identify the developmental principles of fatal GL, fluorescence microscopy and Western blot analysis of CS and control patients is presented here. CS is visualized macroscopically by positron emission tomography (PET)/ computed tomography (CT). A battery of antibodies is used to determine structural, cell cycle and inflammatory markers. GL consist of CD68+, CD163+ and CD206+ macrophages surrounded by T-cells within fibrotic areas. Cell cycle markers such as phospho-histone H3, phospho-Aurora and Ki67 were moderately present; however, the phosphorylated ERM (ezrin, radixin and moesin) and Erk1/2 proteins, strong expression of the myosin motor protein and the macrophage transcription factor PU.1 indicate highly active GL. Mild apoptosis is consistent with PI3 kinase and Akt activation. Massive amounts of the IL-1R antagonist reflect a mild activation of stress and inflammatory pathways in GL. High levels of oncostatin M and the Reg3A and Reg3γ chemokines are in accordance with macrophage accumulation in areas of remodeling cardiomyocytes. We conclude that the formation of GL occurs mainly through chemoattraction and less by proliferation of macrophages. Furthermore, activation of the oncostatin/Reg3 axis might help at first to wall-off substances but might initiate the chronic development of heart failure.

Entities:  

Keywords:  cell signaling; chemoattraction; chemokine; dedifferentiation; heart failure; inflammation; interleukin-1 receptor antagonist; macrophage; myocarditis; remodeling

Year:  2021        PMID: 33923774     DOI: 10.3390/ijms22084148

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  3 in total

1.  Special Issue "Molecular and Cellular Mechanisms of Action of Markers of Tissue Degeneration".

Authors:  Carlos Gutierrez-Merino; Ana M Mata
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

2.  Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis.

Authors:  Florence Jeny; Jean-François Bernaudin; Dominique Valeyre; Marianne Kambouchner; Marina Pretolani; Hilario Nunes; Carole Planès; Valérie Besnard
Journal:  Front Immunol       Date:  2021-08-11       Impact factor: 7.561

Review 3.  The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.

Authors:  Thomas Kubin; Praveen Gajawada; Peter Bramlage; Stefan Hein; Benedikt Berge; Ayse Cetinkaya; Heiko Burger; Markus Schönburg; Wolfgang Schaper; Yeong-Hoon Choi; Manfred Richter
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.